These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34984578)
1. LncRNA LOXL1-AS1 Facilitates the Oncogenic Character in Cervical Cancer by the miR-526b-5p /LYPLA1 Axis. Zhang Y; Zheng M; Zhang L; Yuan P; Zhou J; Wang Y; Wang H Biochem Genet; 2022 Aug; 60(4):1298-1312. PubMed ID: 34984578 [TBL] [Abstract][Full Text] [Related]
2. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis. Guo T; Peng S; Liu D; Li Y Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA LOXL1-AS1 functions as an oncogene in cervical squamous cell carcinoma by sponging miR-21. Bai H; Li X; Wu S Arch Physiol Biochem; 2023 Feb; 129(1):143-147. PubMed ID: 32881598 [TBL] [Abstract][Full Text] [Related]
4. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis. Yi B; Li H; Cai H; Lou X; Yu M; Li Z J Cell Mol Med; 2022 Jan; 26(2):475-490. PubMed ID: 34890108 [TBL] [Abstract][Full Text] [Related]
5. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway. Zhang P; Zhao F; Jia K; Liu X Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607 [TBL] [Abstract][Full Text] [Related]
6. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis. Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209 [TBL] [Abstract][Full Text] [Related]
7. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway. Sun Q; Li J; Li F; Li H; Bei S; Zhang X; Feng L Cell Prolif; 2019 Nov; 52(6):e12687. PubMed ID: 31468594 [TBL] [Abstract][Full Text] [Related]
8. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related]
9. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2. Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653 [TBL] [Abstract][Full Text] [Related]
10. Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma. Feng Z; Ye Z; Xie J; Chen W; Li W; Xing C Biol Direct; 2021 Dec; 16(1):24. PubMed ID: 34863279 [TBL] [Abstract][Full Text] [Related]
11. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2. Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938 [TBL] [Abstract][Full Text] [Related]
12. Targeted-regulating of miR-515-5p by LncRNA LOXL1-AS1 on the proliferation and migration of trophoblast cells. Zhang L; Wan Q; Zhou H Exp Mol Pathol; 2021 Feb; 118():104588. PubMed ID: 33278425 [TBL] [Abstract][Full Text] [Related]
13. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression. Yang X; Xing G; Liu S; Li B; He Y; Wang F Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897 [TBL] [Abstract][Full Text] [Related]
14. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis. Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway. Cheng X; Liu Z; Zhang H; Lian Y Cell Cycle; 2021 Sep; 20(17):1663-1680. PubMed ID: 34334119 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2. Hou S; Zhang X; Yang J Exp Cell Res; 2022 Jan; 410(1):112929. PubMed ID: 34793775 [TBL] [Abstract][Full Text] [Related]
18. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p. Li GH; Yu JH; Yang B; Gong FC; Zhang KW Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194 [TBL] [Abstract][Full Text] [Related]
19. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression. Liu Y; Guo C; Li F; Wu L Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis. Yan F; Ma Y; Liu L; Li L; Deng J; Sun J J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]